Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
33.20
-0.70 (-2.06%)
Apr 30, 2025, 4:42 PM CET
-51.18%
Market Cap 607.57M
Revenue (ttm) 345.76M
Net Income (ttm) -6.10M
Shares Out 18.36M
EPS (ttm) -0.33
PE Ratio n/a
Forward PE 26.17
Dividend n/a
Ex-Dividend Date n/a
Volume 4,718
Average Volume 16,192
Open 34.00
Previous Close 33.90
Day's Range 33.10 - 34.50
52-Week Range 29.90 - 73.00
Beta 0.19
RSI 40.55
Earnings Date May 22, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 886
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.